# Towards Simple and Non-invasive Assessment of Residual Beta-cell Function in Type 1 Diabetes

> **NCT01227538** · — · COMPLETED · sponsor: **University Hospitals Bristol and Weston NHS Foundation Trust** · enrollment: 17 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **OTHER:** Mixed meal stimulated urinary C peptide for the assessment of residual beta cell function

## Key facts

- **NCT ID:** NCT01227538
- **Lead sponsor:** University Hospitals Bristol and Weston NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01227538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01227538, "Towards Simple and Non-invasive Assessment of Residual Beta-cell Function in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01227538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*